Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
166.9 INR | -0.57% | -2.17% | +3.76% |
Apr. 18 | Marksans Pharma's Goa Facility Gets Five Inspectional Observations from US FDA | MT |
Feb. 14 | Transcript : Marksans Pharma Limited, Q3 2024 Earnings Call, Feb 14, 2024 |
Sales 2024 * | 21.58B 259M | Sales 2025 * | 26.33B 316M | Capitalization | 75.75B 910M |
---|---|---|---|---|---|
Net income 2024 * | 3.34B 40.05M | Net income 2025 * | 4.07B 48.82M | EV / Sales 2024 * | 3.51 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.88 x |
P/E ratio 2024 * |
22.7
x | P/E ratio 2025 * |
18.6
x | Employees | 852 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 55.99% |
Latest transcript on Marksans Pharma Limited
1 day | -0.57% | ||
1 week | -2.17% | ||
Current month | +10.13% | ||
1 month | +14.71% | ||
3 months | +14.32% | ||
6 months | +64.51% | ||
Current year | +3.76% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 52 | 92-04-15 | |
Director of Finance/CFO | 54 | 02-09-05 | |
Compliance Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Sunny Sharma
BRD | Director/Board Member | 49 | 21-08-10 |
Chief Executive Officer | 52 | 92-04-15 | |
Director/Board Member | 52 | 14-09-24 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-25 | 166.9 | -0.57% | 92,766 |
24-04-24 | 167.8 | -0.94% | 98,746 |
24-04-23 | 169.4 | +0.95% | 144,938 |
24-04-22 | 167.8 | -3.76% | 340,585 |
24-04-19 | 174.4 | +2.23% | 564,556 |
Delayed Quote Bombay S.E., April 25, 2024 at 06:00 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+24.17% | 562B | |
-6.33% | 358B | |
+19.90% | 322B | |
+7.95% | 297B | |
+13.45% | 219B | |
+6.04% | 199B | |
-10.51% | 196B | |
-12.26% | 149B | |
-6.47% | 146B |
- Stock Market
- Equities
- MARKSANS Stock
- MARKSANS Stock